{"id":43509,"date":"2026-07-27T11:50:56","date_gmt":"2026-07-27T11:50:56","guid":{"rendered":"https:\/\/eurekainfomed.it\/en\/?p=43509"},"modified":"2026-07-29T07:16:27","modified_gmt":"2026-07-29T07:16:27","slug":"signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks","status":"publish","type":"post","link":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/","title":{"rendered":"Signal Detection in Pharmacovigilance: identifying signals before they become risks"},"content":{"rendered":"

The safety of a medicinal product depends not only on the collection of reports of suspected adverse reactions, but also on the ability to systematically interpret the available information. In this context, signal detection<\/strong> is one of the core activities of pharmacovigilance, as it enables the early identification of emerging signals that may require further assessment.<\/p>\n

Through the continuous analysis of data from multiple sources, pharmaceutical companies and regulatory authorities can monitor the evolution of a medicine’s benefit-risk profile and promptly identify information that may be relevant for the protection of public health.<\/p>\n

What is a safety signal?<\/strong><\/h4>\n

In pharmacovigilance, a safety signal<\/strong> is information arising from one or multiple sources that suggests a new potentially causal association between a medicinal product and an adverse event, or a new aspect of a known association, such as a different frequency, increased severity, or occurrence in specific patient populations.<\/p>\n

It is important to emphasize that a signal does not constitute proof of causality. Rather, it indicates the presence of information that requires structured investigation. In other words, a signal is a hypothesis that must be evaluated and confirmed through a scientific and regulatory assessment process.<\/p>\n

Its value lies precisely in the ability to identify information at an early stage that, if confirmed, could alter the safety profile of a medicinal product.<\/p>\n

How are signals identified?<\/strong><\/h4>\n

Signal detection is based on the integrated analysis of data from multiple sources, including spontaneous reports collected in pharmacovigilance databases such as EudraVigilance, clinical and observational studies, patient registries, scientific literature, and real-world clinical data.<\/p>\n

Reviewing these sources collectively helps identify patterns that may not be apparent when individual cases are assessed in isolation. For example, events that initially appear unrelated may acquire greater significance when evaluated alongside similar reports originating from different settings.<\/p>\n

Statistical tools and scientific assessment activities support this process. Among the most widely used disproportionality methods are the Proportional Reporting Ratio (PRR)<\/strong>, Reporting Odds Ratio (ROR)<\/strong>, Information Component (IC)<\/strong>, and other algorithms used within major international pharmacovigilance databases. These methodologies help identify drug-event associations that are reported more frequently than would be expected based on the overall reporting data.<\/p>\n

However, a statistical association does not automatically indicate the existence of a risk or a causal relationship. Algorithms can highlight potential anomalies in reporting patterns, but final conclusions always require expert evaluation by pharmacovigilance and drug safety specialists.<\/p>\n

From signal identification to signal assessment<\/strong><\/h4>\n

Signal detection represents only the first step in a broader signal management<\/strong> process.<\/p>\n

According to the Good Pharmacovigilance Practices (GVP), the process includes several stages: detection, validation, confirmation, analysis and prioritisation, assessment, and, where necessary, recommendation for action<\/strong>. Only after these evaluations have been completed can it be determined whether additional regulatory measures or risk minimization activities are required.<\/p>\n

During signal assessment, several factors are considered:<\/p>\n

    \n
  • quality and completeness of available reports;<\/li>\n
  • number of observed cases;<\/li>\n
  • clinical consistency across reported cases;<\/li>\n
  • biological plausibility of the association;<\/li>\n
  • presence of potential confounding factors;<\/li>\n
  • data from clinical trials, observational studies, and real-world practice;<\/li>\n
  • evidence available in the scientific literature.<\/li>\n<\/ul>\n

    The objective is not to confirm a risk as quickly as possible, but rather to evaluate the totality of available evidence using a rigorous scientific approach.<\/p>\n

    When does a signal become a confirmed risk?<\/strong><\/h4>\n

    An essential aspect of signal detection is that not all signals are ultimately confirmed<\/strong>.<\/p>\n

    Many signals originate from preliminary observations that are not supported after further scientific evaluation. In some situations, the observed event may be explained by the patient’s underlying disease; in others, by concomitant treatments or a simple temporal coincidence.<\/p>\n

    Confirming a risk requires a comprehensive assessment of all available information. Experts examine the temporal relationship between drug exposure and the event, evaluate the existence of similar cases, assess biological plausibility, and consider findings from clinical trials, observational studies, and other data sources.<\/p>\n

    When the accumulated evidence sufficiently supports an association between a medicinal product and an adverse event, the signal may be recognized as a confirmed risk or as a modification of an already known risk.<\/p>\n

    In such cases, several regulatory actions may be considered, including:<\/p>\n

      \n
    • updates to the Summary of Product Characteristics (SmPC);<\/li>\n
    • introduction of new warnings or precautions;<\/li>\n
    • safety communications for healthcare professionals;<\/li>\n
    • implementation of risk minimization measures;<\/li>\n
    • restrictions on the use of the medicinal product;<\/li>\n
    • in the most serious cases, suspension or withdrawal from the market.<\/li>\n<\/ul>\n

      Conclusion<\/strong><\/h4>\n

      Signal detection is one of the pillars of modern pharmacovigilance and plays a critical role in the continuous monitoring of medicinal product safety.<\/p>\n

      Through the systematic analysis of available information, it enables the early identification of signals that may affect the benefit-risk profile of a medicine and require regulatory action or additional risk minimization measures.<\/p>\n

      A signal, however, is not equivalent to a confirmed risk. It is an indication that must be investigated through an integrated assessment of clinical, epidemiological, statistical, and regulatory evidence. Only through this process can it be determined whether a suspected association should result in concrete action.<\/p>\n

      In this way, pharmacovigilance continues to protect patients through continuous, evidence-based, and proportionate safety surveillance throughout the entire lifecycle of medicinal products.<\/p>\n

      Sources<\/p>\n

        \n
      1. European Medicines Agency (EMA) \u2013 Guideline on Good Pharmacovigilance Practices (GVP), Module IX: Signal Management<\/em>.<\/li>\n
      2. European Medicines Agency (EMA) \u2013 GVP Module IX Addendum I: Methodological Aspects of Signal Detection from Spontaneous Reports of Suspected Adverse Reactions<\/em>.<\/li>\n
      3. Uppsala Monitoring Centre (WHO-UMC) \u2013 Signal Management at UMC<\/em>.<\/li>\n
      4. CIOMS Working Group VIII \u2013 Practical Aspects of Signal Detection in Pharmacovigilance<\/em>.<\/li>\n
      5. ENCePP \u2013 Signal Detection Methodology and Application<\/em>.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

        The safety of a medicinal product depends not only on the collection of reports of suspected adverse reactions, but also on the ability to systematically interpret the available information. In…<\/p>\n","protected":false},"author":16,"featured_media":43510,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25,4],"tags":[],"class_list":["post-43509","post","type-post","status-publish","format-standard","has-post-thumbnail","category-pharmacovigilance","category-news"],"yoast_head":"\nSignal Detection in Pharmacovigilance: identifying signals<\/title>\n<meta name=\"description\" content=\"Learn how signal detection in pharmacovigilance helps identify, evaluate, and monitor potential safety signals to detect emerging risks\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Signal Detection in Pharmacovigilance: identifying signals\" \/>\n<meta property=\"og:description\" content=\"Learn how signal detection in pharmacovigilance helps identify, evaluate, and monitor potential safety signals to detect emerging risks\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/\" \/>\n<meta property=\"og:site_name\" content=\"Eureka Info Med\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-27T11:50:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-29T07:16:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/07\/Signal-Detection-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"EleonoraHay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"EleonoraHay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/\"},\"author\":{\"name\":\"EleonoraHay\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\"},\"headline\":\"Signal Detection in Pharmacovigilance: identifying signals before they become risks\",\"datePublished\":\"2026-07-27T11:50:56+00:00\",\"dateModified\":\"2026-07-29T07:16:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/\"},\"wordCount\":919,\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Signal-Detection-2.png\",\"articleSection\":[\"Pharmacovigilance\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/\",\"name\":\"Signal Detection in Pharmacovigilance: identifying signals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Signal-Detection-2.png\",\"datePublished\":\"2026-07-27T11:50:56+00:00\",\"dateModified\":\"2026-07-29T07:16:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\"},\"description\":\"Learn how signal detection in pharmacovigilance helps identify, evaluate, and monitor potential safety signals to detect emerging risks\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Signal-Detection-2.png\",\"contentUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Signal-Detection-2.png\",\"width\":1536,\"height\":1024,\"caption\":\"Signal detection combines safety data from multiple sources to identify, assess, and manage potential risks associated with medicinal products.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Signal Detection in Pharmacovigilance: identifying signals before they become risks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\",\"name\":\"Eureka Info Med\",\"description\":\"documentazione medico-scientifica e farmacovigilanza\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\",\"name\":\"EleonoraHay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"caption\":\"EleonoraHay\"},\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/author\\\/eleonorahay\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Signal Detection in Pharmacovigilance: identifying signals","description":"Learn how signal detection in pharmacovigilance helps identify, evaluate, and monitor potential safety signals to detect emerging risks","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/","og_locale":"en_US","og_type":"article","og_title":"Signal Detection in Pharmacovigilance: identifying signals","og_description":"Learn how signal detection in pharmacovigilance helps identify, evaluate, and monitor potential safety signals to detect emerging risks","og_url":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/","og_site_name":"Eureka Info Med","article_published_time":"2026-07-27T11:50:56+00:00","article_modified_time":"2026-07-29T07:16:27+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/07\/Signal-Detection-2.png","type":"image\/png"}],"author":"EleonoraHay","twitter_card":"summary_large_image","twitter_misc":{"Written by":"EleonoraHay","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/#article","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/"},"author":{"name":"EleonoraHay","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55"},"headline":"Signal Detection in Pharmacovigilance: identifying signals before they become risks","datePublished":"2026-07-27T11:50:56+00:00","dateModified":"2026-07-29T07:16:27+00:00","mainEntityOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/"},"wordCount":919,"image":{"@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/07\/Signal-Detection-2.png","articleSection":["Pharmacovigilance","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/","url":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/","name":"Signal Detection in Pharmacovigilance: identifying signals","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/#primaryimage"},"image":{"@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/07\/Signal-Detection-2.png","datePublished":"2026-07-27T11:50:56+00:00","dateModified":"2026-07-29T07:16:27+00:00","author":{"@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55"},"description":"Learn how signal detection in pharmacovigilance helps identify, evaluate, and monitor potential safety signals to detect emerging risks","breadcrumb":{"@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/#primaryimage","url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/07\/Signal-Detection-2.png","contentUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/07\/Signal-Detection-2.png","width":1536,"height":1024,"caption":"Signal detection combines safety data from multiple sources to identify, assess, and manage potential risks associated with medicinal products."},{"@type":"BreadcrumbList","@id":"https:\/\/eurekainfomed.it\/en\/signal-detection-in-pharmacovigilance-identifying-signals-before-they-become-risks\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurekainfomed.it\/en\/"},{"@type":"ListItem","position":2,"name":"Signal Detection in Pharmacovigilance: identifying signals before they become risks"}]},{"@type":"WebSite","@id":"https:\/\/eurekainfomed.it\/en\/#website","url":"https:\/\/eurekainfomed.it\/en\/","name":"Eureka Info Med","description":"documentazione medico-scientifica e farmacovigilanza","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurekainfomed.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55","name":"EleonoraHay","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","caption":"EleonoraHay"},"url":"https:\/\/eurekainfomed.it\/en\/author\/eleonorahay\/"}]}},"_links":{"self":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/comments?post=43509"}],"version-history":[{"count":1,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43509\/revisions"}],"predecessor-version":[{"id":43511,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43509\/revisions\/43511"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media\/43510"}],"wp:attachment":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media?parent=43509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/categories?post=43509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/tags?post=43509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}